Nuvation Bio
Price & Volume
Stats
See more52W Range | $1.57-$9.75 |
Market Cap | $1.6B |
Shares Short | 50M |
Financials
See moreRevenue (12 Mos) | $143M |
Revenue Growth (YoY) | 2,598.7% |
Gross Profit (12 Mos) | $129.8M |
Diluted EPS | -$0.43 |
News
See moreYahoo Finance • 13 days ago
Stanley Druckenmiller Just Exited Alphabet. TCI Fund Management Is Buying.
Yahoo Finance • 15 days ago
Nuvation Bio to Collaborate with Thermo Fisher Scientific for U.S.-Based Manufacturing of IBTROZI® for ROS1-Positive Non-Small Cell Lung Cancer
Yahoo Finance • 22 days ago
Nuvation Bio's Supplemental NDA With Updated Data For IBTROZI Wins FDA Acceptance
Yahoo Finance • last month
Nuvation Bio Inc (NUVB): Take a Look at Glioma Revenue Potential
About
CEO | Dr. David T. Hung M.D. |
CFO | Mr. Philippe Pierre Sauvage |
Address | 1500 Broadway, New York, NY, United States, 10036 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 307 |